166 related articles for article (PubMed ID: 36863106)
1. Association between the loudness dependence of auditory evoked potential, serotonergic neurotransmission and treatment outcome in patients with depression.
Ip CT; Ganz M; Ozenne B; Olbrich S; Beliveau V; Dam VH; Köhler-Forsberg K; Jørgensen MB; Frøkjær VG; Knudsen GM
Eur Neuropsychopharmacol; 2023 May; 70():32-44. PubMed ID: 36863106
[TBL] [Abstract][Full Text] [Related]
2. Prediction of long-term treatment response to selective serotonin reuptake inhibitors (SSRIs) using scalp and source loudness dependence of auditory evoked potentials (LDAEP) analysis in patients with major depressive disorder.
Lee BH; Park YM; Lee SH; Shim M
Int J Mol Sci; 2015 Mar; 16(3):6251-65. PubMed ID: 25794285
[TBL] [Abstract][Full Text] [Related]
3. Association between the loudness dependence of auditory evoked potentials and age in patients with schizophrenia and depression.
Jang KI; Kim S; Lee C; Chae JH
J Int Med Res; 2022 Jul; 50(7):3000605221109789. PubMed ID: 35808808
[TBL] [Abstract][Full Text] [Related]
4. Affective disorders and the loudness dependence of the auditory evoked potential: Serotonin and beyond.
Fitzgerald PJ
Neurosci Lett; 2024 Mar; 827():137734. PubMed ID: 38499279
[TBL] [Abstract][Full Text] [Related]
5. Response prediction to antidepressants using scalp and source-localized loudness dependence of auditory evoked potential (LDAEP) slopes.
Jaworska N; Blondeau C; Tessier P; Norris S; Fusee W; Blier P; Knott V
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():100-7. PubMed ID: 23360662
[TBL] [Abstract][Full Text] [Related]
6. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder.
Juckel G; Pogarell O; Augustin H; Mulert C; Müller-Siecheneder F; Frodl T; Mavrogiorgou P; Hegerl U
J Clin Psychiatry; 2007 Aug; 68(8):1206-12. PubMed ID: 17854244
[TBL] [Abstract][Full Text] [Related]
7. Relationship between SSRI-induced sexual dysfunction and central serotonergic activity based on the loudness dependence of auditory evoked potentials.
Park YM
Psychopharmacology (Berl); 2014 Feb; 231(3):551-5. PubMed ID: 24005532
[TBL] [Abstract][Full Text] [Related]
8. Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants.
Simmons JG; Nathan PJ; Berger G; Allen NB
Psychopharmacology (Berl); 2011 Sep; 217(1):101-10. PubMed ID: 21465243
[TBL] [Abstract][Full Text] [Related]
9. Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex.
Wutzler A; Winter C; Kitzrow W; Uhl I; Wolf RJ; Heinz A; Juckel G
Neuropsychopharmacology; 2008 Dec; 33(13):3176-81. PubMed ID: 18463629
[TBL] [Abstract][Full Text] [Related]
10. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression.
Gallinat J; Bottlender R; Juckel G; Munke-Puchner A; Stotz G; Kuss HJ; Mavrogiorgou P; Hegerl U
Psychopharmacology (Berl); 2000 Mar; 148(4):404-11. PubMed ID: 10928314
[TBL] [Abstract][Full Text] [Related]
11. The relationship between auditory evoked potentials and symptoms of attention-deficit/hyperactivity disorder in adult patients with major depressive disorder.
Kim JS; Kim DW; Kwon YJ; Lee HY; Kim S; Shim SH
Int J Psychophysiol; 2019 Aug; 142():50-56. PubMed ID: 31207261
[TBL] [Abstract][Full Text] [Related]
12. Examining the underpinnings of loudness dependence of auditory evoked potentials with positron emission tomography.
Pillai RLI; Bartlett EA; Ananth MR; Zhu C; Yang J; Hajcak G; Parsey RV; DeLorenzo C
Neuroimage; 2020 Jun; 213():116733. PubMed ID: 32169543
[TBL] [Abstract][Full Text] [Related]
13. An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline.
Guille V; Croft RJ; O'Neill BV; Illic S; Phan KL; Nathan PJ
Hum Psychopharmacol; 2008 Apr; 23(3):231-41. PubMed ID: 18196604
[TBL] [Abstract][Full Text] [Related]
14. Scalp- and sLORETA-derived loudness dependence of auditory evoked potentials (LDAEPs) in unmedicated depressed males and females and healthy controls.
Jaworska N; Blier P; Fusee W; Knott V
Clin Neurophysiol; 2012 Sep; 123(9):1769-78. PubMed ID: 22425485
[TBL] [Abstract][Full Text] [Related]
15. Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function.
Nathan PJ; Segrave R; Phan KL; O'Neill B; Croft RJ
Hum Psychopharmacol; 2006 Jan; 21(1):47-52. PubMed ID: 16317803
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity.
Juckel G; Gallinat J; Riedel M; Sokullu S; Schulz C; Möller HJ; Müller N; Hegerl U
Schizophr Res; 2003 Nov; 64(2-3):115-24. PubMed ID: 14613676
[TBL] [Abstract][Full Text] [Related]
17. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
18. The loudness dependence of auditory evoked potentials and effects of psychopathology and psychopharmacotherapy in psychiatric inpatients.
Ostermann J; Uhl I; Köhler E; Juckel G; Norra C
Hum Psychopharmacol; 2012 Nov; 27(6):595-604. PubMed ID: 24446538
[TBL] [Abstract][Full Text] [Related]
19. The loudness dependence of auditory evoked potentials (LDAEP) as an indicator of serotonergic dysfunction in patients with predominant schizophrenic negative symptoms.
Wyss C; Hitz K; Hengartner MP; Theodoridou A; Obermann C; Uhl I; Roser P; Grünblatt E; Seifritz E; Juckel G; Kawohl W
PLoS One; 2013; 8(7):e68650. PubMed ID: 23874705
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic central tone in Parkinson's disease with fatigue: Evidence from the loudness dependence of auditory evoked potentials (LDAEP).
Pauletti C; Mannarelli D; Locuratolo N; Maffucci A; Currà A; Marinelli L; Fattapposta F
Neurosci Lett; 2021 Nov; 764():136242. PubMed ID: 34509567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
